Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_14578 | 33 | 0.69 | Mlig455_033066 | Neo: - Age: - |
Mlig455_033066 {REF} {Length: 2292} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=137.2]} {Smed: dd_Smed_v6_19599_0_1, dd_Smed_v6_19599_0_1, [Score=63.9, Expect=1e-10]} {RNA1310_28762} {RNA815_42177} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -9.76 | 0.916 | 1.00000 | 1.00000 | |
RegionR2 | 5.091 | 0.916 | 0.15219 | 0.48788 | |
RegionR3 | 4.027 | 0.916 | 0.20837 | 0.74881 | |
RegionR4 | -0.396 | 0.916 | 0.99970 | 1.00000 | |
RegionR5 | 3.569 | 0.916 | 0.01457 | 0.07655 | |
RegionR6 | 0.892 | 0.916 | 0.99965 | 1.00000 | |
RegionR7 | -1.221 | 0.916 | 0.99979 | 1.00000 | |
RegionR8 | -2.201 | 0.916 | 0.99939 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.143 | 0.916 | 1.00000 | 1.00000 | |
RegenerationR2 | -0.254 | 0.916 | 0.27120 | 0.71694 | |
RegenerationR3 | 1.362 | 0.916 | 0.08393 | 0.47367 | |
RegenerationR4 | 0.569 | 0.916 | 0.30499 | 0.74661 | |
RegenerationR5 | -2.25 | 0.916 | 0.19378 | 0.62562 | |
RegenerationR6 | 2.206 | 0.916 | 0.12710 | 0.43844 | |
RegenerationBL | -0.17 | 0.916 | 0.99986 | 1.00000 | |
RegenerationTP | -0.899 | 0.916 | 0.99976 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_14578 | 33 | 0.69 | Mlig455_033066 | Neo: - Age: - |
3 | - | - | 1.000 | 1.000 | 1.000 | - | Mlig455_033066 {REF} {Length: 2292} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=137.2]} {Smed: dd_Smed_v6_19599_0_1, dd_Smed_v6_19599_0_1, [Score=63.9, Expect=1e-10]} {RNA1310_28762} {RNA815_42177} | |
2. | MligTC455_52065 | 35 | 0.73 | Mlig455_043270, Mlig455_043296 | Neo: Int S/G2/M Age: - |
1.905 | - | - | 0.951 | - | 0.954 | - | Mlig455_043270 {REF} {Length: 1377} {NoTransDecoderORF} {RNA1310_78448} Mlig455_043296 {REF} {Length: 1020} {NoTransDecoderORF} {RNA1310_78448} |
|
3. | MligTC455_38926 | 75 | 1.56 | Mlig455_036654 | Neo: - Age: - |
1.862 | - | - | 0.903 | - | 0.959 | - | Mlig455_036654 {REF} {Length: 654} {TRANSSPLICED} {RNA1509_25556} {RNA1310_11387.2} {RNA815_48752} | |
4. | MligTC455_17564 | 59 | 1.23 | Mlig455_016424 | Neo: - Age: - |
1.797 | - | - | 0.955 | - | 0.842 | - | Mlig455_016424 {REF} {Length: 6368} {RNA1509_56228} {RNA1310_86983} {RNA815_46718} | |
5. | MligTC455_52544 | 250 | 5.21 | Mlig455_030562 | Neo: - Age: Up-Down-Down Region-enriched R8: 3.544/0.00108 |
1.746 | - | - | 0.964 | 0.782 | - | - | Mlig455_030562 {REF} {Length: 1251} {RNA1310_32103} {RNA815_22028} | |
6. | MligTC455_19211 | 107 | 2.23 | Mlig455_052588 | Neo: - Age: - Region-enriched R8: 3.795/0.01587 |
1.74 | - | - | 0.959 | - | 0.781 | - | Mlig455_052588 {REF} {Length: 2340} {Celegans: WBGene00019180, H10D18.5, [RH, Score=62.4, Expect=6e-11]} {Smed: dd_Smed_v6_10251_0_1, dd_Smed_v6_10251_0_1, [RH, Score=95.9, Expect=2e-23]} {RNA1509_8096} {RNA1310_25906} {RNA815_14581.1} | |
7. | MligTC455_20517 | 89 | 1.86 | Mlig455_023814 | Neo: - Age: logFC(26M/2M)=0.507 |
QRSL1 | 1.698 | - | - | 0.956 | - | 0.742 | - | Mlig455_023814 {REF} {Length: 3292} {TRANSSPLICED} {Pfam: Amidase [PF01425.23, score=219.5]} {Human: ENSG00000130348, QRSL1, QRSL1, glutaminyl-tRNA amidotransferase subunit A, [Score=104, Expect=3e-24]} {Mouse: ENSMUSG00000019863, Qrsl1, glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1, [Score=103, Expect=5e-23]} {Dmel: FBgn0260779, GatA, Glutamyl-tRNA amidotransferase, subunit A, [Score=105, Expect=5e-24]} {Celegans: WBGene00021508, Y41D4A.6, Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial, [Score=106, Expect=2e-24]} {Smed: dd_Smed_v6_12029_0_1, dd_Smed_v6_12029_0_1, [Score=96.3, Expect=3e-21]} {RNA1310_26342} {RNA815_31425} |
8. | MligTC455_26774 | 54 | 1.12 | Mlig455_038949 | Neo: - |
ANO7 | 1.691 | - | - | 0.962 | - | 0.729 | - | Mlig455_038949 {REF} {Length: 4653} {Pfam: Calcium-activated chloride channel [PF04547.14, score=519.7]; Dimerisation domain of Ca+-activated chloride-channel, anoctamin [PF16178.7, score=243.5]} {Human: ENSG00000146205, ANO7, anoctamin 7, [RH, Score=875, Expect=0.0]} {Mouse: ENSMUSG00000034107, Ano7, anoctamin 7, [RH, Score=886, Expect=0.0]} {Dmel: FBgn0038721, subdued, [RH, Score=596, Expect=0.0]} {Celegans: WBGene00010138, anoh-1, Anoctamin, [Score=242, Expect=6e-68]} {Smed: dd_Smed_v6_4761_0_1, dd_Smed_v6_4761_0_1, [RH, Score=1092, Expect=0.0]} {RNA1509_15570} {RNA1310_5583.1} {RNA815_1646.1} |
9. | MligTC455_43701 | 215 | 4.49 | Mlig455_022782, Mlig455_022969 | Neo: - Age: Down-Up-Down |
MEIG1 | 1.683 | - | - | 0.956 | - | 0.727 | - | Mlig455_022782 {REF} {Length: 1226} {TRANSSPLICED} {Pfam: Meiosis-expressed [PF15163.8, score=122.7]} {Human: ENSG00000197889, MEIG1, meiosis/spermiogenesis associated 1, [Score=94.0, Expect=2e-26]} {Mouse: ENSMUSG00000026650, Meig1, meiosis expressed gene 1, [Score=89.7, Expect=8e-25]} {Smed: dd_Smed_v6_4620_0_1, dd_Smed_v6_4620_0_1, [Score=96.3, Expect=8e-28]} {RNA1509_25277, RNA1509_34822, RNA1509_49238} {RNA1310_49032, RNA1509_25277, RNA1509_34822, RNA1509_49238} {RNA1509_25277, RNA1509_34822, RNA1509_49238, RNA815_10990} Mlig455_022969 {REF} {Length: 1111} {TRANSSPLICED} {Pfam: Meiosis-expressed [PF15163.8, score=122.7]} {Human: ENSG00000197889, MEIG1, meiosis/spermiogenesis associated 1, [Score=94.0, Expect=2e-26]} {Mouse: ENSMUSG00000026650, Meig1, meiosis expressed gene 1, [Score=89.7, Expect=8e-25]} {Smed: dd_Smed_v6_4620_0_1, dd_Smed_v6_4620_0_1, [Score=96.3, Expect=8e-28]} {RNA1509_49238} {RNA1310_49032} {RNA815_10990} |
10. | MligTC455_40223 | 172 | 3.59 | Mlig455_016264 | Neo: - Age: - Region-enriched R8: 3.704/0.01076 |
CHRNA10 | 1.667 | - | - | 0.950 | 0.717 | - | - | Mlig455_016264 {REF} {Length: 4782} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=169.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=109.0]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=230, Expect=2e-68]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=225, Expect=1e-66]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=233, Expect=9e-70]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=236, Expect=2e-70]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=215, Expect=6e-63]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=280, Expect=9e-87]} {RNA1509_35668} {RNA1310_11720.1} {RNA815_6827} |
11. | MligTC455_45720 | 122 | 2.53 | Mlig455_017856 | Neo: - Age: Up-Down-Down |
0.998 | - | - | 0.998 | - | - | - | Mlig455_017856 {REF} {Length: 4797} {TRANSSPLICED} {RNA1509_41174} {RNA1310_29724} {RNA815_13192} | |
12. | MligTC455_22917 | 44 | 0.91 | Mlig455_024178 | Neo: - Age: - |
DOC2B | 0.995 | - | - | 0.995 | - | - | - | Mlig455_024178 {REF} {Length: 3465} {Pfam: C2 domain [PF00168.32, score=45.3]} {Human: ENSG00000272670, DOC2B, double C2 domain beta, [Score=88.2, Expect=2e-21]; ENSG00000272636, DOC2B, double C2 domain beta, [Score=88.2, Expect=2e-21]; ENSG00000149927, DOC2A, double C2 domain alpha, [Score=85.1, Expect=2e-20]; ENSG00000089169, RPH3A, rabphilin 3A, [Score=84.7, Expect=5e-20]} {Mouse: ENSMUSG00000020848, Doc2b, double C2, beta, [Score=89.4, Expect=5e-22]; ENSMUSG00000052301, Doc2a, double C2, alpha, [Score=85.5, Expect=1e-20]} {Dmel: FBgn0030230, Rph, Rabphilin, [Score=78.6, Expect=3e-18]} {Celegans: WBGene00004316, rbf-1, Rabphilin-1, [Score=64.3, Expect=3e-13]} {Smed: dd_Smed_v6_12977_0_1, dd_Smed_v6_12977_0_1, [Score=70.5, Expect=1e-15]} {RNA1509_24504} {RNA1310_21933.1} {RNA815_52770} |
13. | MligTC455_38571 | 152 | 3.16 | Mlig455_065241 | Neo: - Age: - |
0.994 | - | - | 0.994 | - | - | - | Mlig455_065241 {REF} {Length: 5131} {NoTransDecoderORF} {RNA1509_47593} {RNA1310_10205.1} {RNA815_53866} | |
14. | MligTC455_31212 | 97 | 2.02 | Mlig455_028599, Mlig455_056911 | Neo: - Age: - |
0.993 | - | - | - | - | 0.993 | - | Mlig455_028599 {REF} {Length: 600} {NoTransDecoderORF} {RNA1310_114554} {RNA815_54362} Mlig455_056911 {REF} {Length: 602} {NoTransDecoderORF} {RNA1310_114554} {RNA815_54362} |
|
15. | MligTC455_23922 | 8 | 0.17 | Mlig455_001765 | Neo: - Age: Down-Up-Down |
0.992 | - | - | - | - | 0.992 | - | Mlig455_001765 {REF} {Length: 4721} {Pfam: AMP-binding enzyme [PF00501.30, score=68.9]} {RNA1509_37800} {RNA1310_40483} {RNA815_30709} | |
16. | MligTC455_12203 | 8 | 0.17 | Mlig455_061049 | Neo: - Age: - |
0.991 | - | - | - | - | 0.991 | - | Mlig455_061049 {REF} {Length: 1492} {RNA1509_16662} {RNA1310_122445} {RNA815_4833.1} | |
17. | MligTC455_09686 | 4 | 0.08 | Mlig455_061629 | Neo: - Age: - |
0.989 | - | - | - | - | 0.989 | - | Mlig455_061629 {REF} {Length: 1698} {NoTransDecoderORF} {RNA1509_20320} {RNA1310_104302} {RNA815_52785.1} | |
18. | MligTC455_26562 | 51 | 1.05 | Mlig455_003821 | Neo: - Age: - Region-enriched R4: 4.788/0.04787 |
0.989 | - | - | - | - | 0.989 | - | Mlig455_003821 {REF} {Length: 3329} {NoTransDecoderORF} {RNA1509_310} {RNA1310_3669} {RNA815_20255} | |
19. | MligTC455_54226 | 52 | 1.09 | Mlig455_037435, Mlig455_037458 | Neo: - Age: - |
NETO2 | 0.989 | - | - | - | - | 0.989 | - | Mlig455_037435 {REF} {Length: 2663} {Pfam: CUB domain [PF00431.22, score=52.2]; Low-density lipoprotein receptor domain class A [PF00057.20, score=31.7]} {Human: ENSG00000171208, NETO2, neuropilin and tolloid like 2, [Score=96.3, Expect=3e-20]} {Mouse: ENSMUSG00000036902, Neto2, neuropilin (NRP) and tolloid (TLL)-like 2, [Score=97.8, Expect=6e-21]} {Dmel: FBgn0265416, Neto, Neuropilin and tolloid-like, [Score=87.8, Expect=1e-17]} {Celegans: WBGene00019360, neto-1, NETO (NEuropilin and TOlloid-like) homolog, [Score=77.4, Expect=4e-15]} {Smed: dd_Smed_v6_8579_0_1, dd_Smed_v6_8579_0_1, [Score=87.0, Expect=1e-17]} {RNA1310_38111} Mlig455_037458 {REF} {Length: 2349} {Pfam: CUB domain [PF00431.22, score=52.1]; Low-density lipoprotein receptor domain class A [PF00057.20, score=31.7]} {Human: ENSG00000171208, NETO2, neuropilin and tolloid like 2, [RH, Score=144, Expect=9e-37]} {Mouse: ENSMUSG00000036902, Neto2, neuropilin (NRP) and tolloid (TLL)-like 2, [RH, Score=146, Expect=1e-37]} {Dmel: FBgn0265416, Neto, Neuropilin and tolloid-like, [Score=117, Expect=2e-27]} {Celegans: WBGene00019360, neto-1, NETO (NEuropilin and TOlloid-like) homolog, [Score=105, Expect=1e-24]} {Smed: dd_Smed_v6_8579_0_1, dd_Smed_v6_8579_0_1, [Score=115, Expect=6e-27]} {RNA1310_38111} |
20. | MligTC455_02461 | 5 | 0.11 | Mlig455_019900 | Neo: - Age: - |
0.988 | - | - | - | - | 0.988 | - | Mlig455_019900 {REF} {Length: 253} {NoTransDecoderORF} {RNA1509_34377} {RNA1310_100135} | |
21. | MligTC455_47574 | 716 | 14.92 | Mlig455_028318, Mlig455_066192 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=1.060 Region-enriched R2: 1.667/0.01738 |
MAN1C1 | 0.986 | - | - | - | - | 0.986 | - | Mlig455_028318 {REF} {Length: 2839} {TRANSSPLICED} {Pfam: Glycosyl hydrolase family 47 [PF01532.22, score=378.3]; Glycosyl hydrolase family 76 [PF03663.16, score=19.1]} {Human: ENSG00000117643, MAN1C1, mannosidase alpha class 1C member 1, [Score=269, Expect=4e-82]; ENSG00000198162, MAN1A2, mannosidase alpha class 1A member 2, [Score=268, Expect=1e-81]} {Mouse: ENSMUSG00000008763, Man1a2, mannosidase, alpha, class 1A, member 2, [Score=268, Expect=1e-81]; ENSMUSG00000037306, Man1c1, mannosidase, alpha, class 1C, member 1, [Score=267, Expect=1e-81]; ENSMUSG00000003746, Man1a, mannosidase 1, alpha, [Score=263, Expect=2e-79]} {Dmel: FBgn0259170, alpha-Man-Ia, alpha-Mannosidase class I a, [Score=266, Expect=5e-81]} {Celegans: WBGene00008258, mans-2, Mannosyl-oligosaccharide 1,2-alpha-mannosidase C52E4.5, [Score=249, Expect=2e-75]} {Smed: dd_Smed_v6_6801_0_1, dd_Smed_v6_6801_0_1, [Score=265, Expect=2e-81]} {RNA1509_9530} {RNA1310_9474.1} {RNA815_6962} Mlig455_066192 {REF} {Length: 2836} {TRANSSPLICED} {Pfam: Glycosyl hydrolase family 47 [PF01532.22, score=378.3]; Glycosyl hydrolase family 76 [PF03663.16, score=19.1]} {Human: ENSG00000117643, MAN1C1, mannosidase alpha class 1C member 1, [Score=269, Expect=4e-82]; ENSG00000198162, MAN1A2, mannosidase alpha class 1A member 2, [Score=268, Expect=1e-81]} {Mouse: ENSMUSG00000008763, Man1a2, mannosidase, alpha, class 1A, member 2, [Score=268, Expect=1e-81]; ENSMUSG00000037306, Man1c1, mannosidase, alpha, class 1C, member 1, [Score=267, Expect=1e-81]; ENSMUSG00000003746, Man1a, mannosidase 1, alpha, [Score=263, Expect=2e-79]} {Dmel: FBgn0259170, alpha-Man-Ia, alpha-Mannosidase class I a, [Score=266, Expect=5e-81]} {Celegans: WBGene00008258, mans-2, Mannosyl-oligosaccharide 1,2-alpha-mannosidase C52E4.5, [Score=249, Expect=2e-75]} {Smed: dd_Smed_v6_6801_0_1, dd_Smed_v6_6801_0_1, [Score=265, Expect=2e-81]} {RNA1509_53617, RNA1509_9530} {RNA1310_9474.1, RNA1509_53617} {RNA1509_53617, RNA815_6962} |
22. | MligTC455_50029 | 35 | 0.74 | Mlig455_010619, Mlig455_010708 | Neo: - Age: - |
FOXA1 | 0.986 | - | - | - | - | 0.986 | - | Mlig455_010619 {REF} {Length: 1170} {Pfam: Forkhead domain [PF00250.20, score=110.8]} {Human: ENSG00000129514, FOXA1, forkhead box A1, [Score=168, Expect=3e-48]; ENSG00000170608, FOXA3, forkhead box A3, [Score=164, Expect=1e-47]; ENSG00000125798, FOXA2, forkhead box A2, [Score=163, Expect=2e-46]} {Mouse: ENSMUSG00000035451, Foxa1, forkhead box A1, [Score=167, Expect=3e-48]; ENSMUSG00000040891, Foxa3, forkhead box A3, [Score=164, Expect=7e-48]; ENSMUSG00000037025, Foxa2, forkhead box A2, [Score=164, Expect=7e-47]} {Dmel: FBgn0000659, fkh, fork head, [Score=169, Expect=2e-48]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [Score=150, Expect=3e-42]} {Smed: dd_Smed_v6_10718_0_4, dd_Smed_v6_10718_0_4, [Score=175, Expect=2e-51]} Mlig455_010708 {REF} {Length: 1194} {Pfam: Forkhead domain [PF00250.20, score=110.9]} {Human: ENSG00000129514, FOXA1, forkhead box A1, [Score=168, Expect=3e-48]; ENSG00000125798, FOXA2, forkhead box A2, [Score=163, Expect=2e-46]; ENSG00000170608, FOXA3, forkhead box A3, [Score=163, Expect=1e-47]} {Mouse: ENSMUSG00000035451, Foxa1, forkhead box A1, [Score=167, Expect=4e-48]; ENSMUSG00000040891, Foxa3, forkhead box A3, [Score=165, Expect=2e-48]; ENSMUSG00000037025, Foxa2, forkhead box A2, [Score=164, Expect=9e-47]} {Dmel: FBgn0000659, fkh, fork head, [Score=168, Expect=2e-48]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [Score=151, Expect=2e-42]} {Smed: dd_Smed_v6_10718_0_3, dd_Smed_v6_10718_0_3, [Score=175, Expect=2e-51]} |
23. | MligTC455_53285 | 6 | 0.13 | Mlig455_061305 | Neo: - Age: - |
0.986 | - | - | - | - | 0.986 | - | Mlig455_061305 {REF} {Length: 422} {NoTransDecoderORF} | |
24. | MligTC455_30594 | 23 | 0.48 | Mlig455_038529, Mlig455_052221 | Neo: - Age: - |
0.985 | - | - | - | - | 0.985 | - | Mlig455_038529 {REF} {Length: 805} {Pfam: Lecithin retinol acyltransferase [PF04970.15, score=35.1]} {RNA1509_40834} {RNA1310_11051} {RNA815_3523.1} Mlig455_052221 {REF} {Length: 7356} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=40.2]; Mab-21 protein [PF03281.16, score=18.9]} {RNA1509_14346, RNA1509_40834} {RNA1310_11051, RNA1509_14346} {RNA1509_14346, RNA815_3523.1} |
|
25. | MligTC455_41297 | 10 | 0.21 | Mlig455_015247 | Neo: - Age: - |
0.983 | - | - | - | - | 0.983 | - | Mlig455_015247 {REF} {Length: 738} {NoTransDecoderORF} | |
26. | MligTC455_49878 | 31 | 0.65 | Mlig455_050656 | Neo: - Age: - |
CHRNA10 | 0.983 | - | - | - | - | 0.983 | - | Mlig455_050656 {REF} {Length: 1810} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=89.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=81.7]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=148, Expect=2e-39]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=145, Expect=8e-38]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=142, Expect=7e-37]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=142, Expect=4e-37]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=142, Expect=9e-37]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=143, Expect=9e-38]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=141, Expect=7e-37]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=139, Expect=4e-36]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=134, Expect=3e-34]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=126, Expect=9e-32]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=133, Expect=3e-34]} {RNA1310_26175} {RNA815_7952} |
27. | MligTC455_14604 | 21 | 0.43 | Mlig455_014269 | Neo: - Age: - |
0.982 | - | - | - | - | 0.982 | - | Mlig455_014269 {REF} {Length: 2720} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=90.5]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=53.1, Expect=2e-07]} {Smed: dd_Smed_v6_14355_0_1, dd_Smed_v6_14355_0_1, [Score=108, Expect=3e-25]} {RNA1310_19428.1} {RNA815_22602} | |
28. | MligTC455_15053 | 12 | 0.26 | Mlig455_016326 | Neo: - Age: - |
0.982 | - | - | - | - | 0.982 | - | Mlig455_016326 {REF} {Length: 2006} {NoTransDecoderORF} {RNA1509_50409, RNA1509_54815} {RNA1310_146928, RNA1509_50409} {RNA1509_50409, RNA815_32053} | |
29. | MligTC455_19171 | 162 | 3.38 | Mlig455_047844 | Neo: - Age: - |
LRRD1 | 0.982 | - | - | - | - | 0.982 | - | Mlig455_047844 {REF} {Length: 3483} {Pfam: Leucine rich repeat [PF13855.8, score=200.6]; Leucine Rich repeats (2 copies) [PF12799.9, score=161.9]; Leucine-rich repeat [PF14580.8, score=62.9]; Death domain [PF00531.24, score=25.2]; RsmF rRNA methyltransferase first C-terminal domain [PF17126.7, score=19.3]} {Human: ENSG00000240720, LRRD1, leucine rich repeats and death domain containing 1, [RH, Score=265, Expect=2e-76]} {Mouse: ENSMUSG00000040367, Lrrd1, leucine rich repeats and death domain containing 1, [RH, Score=305, Expect=1e-91]} {Dmel: FBgn0038504, Sur-8, [Score=157, Expect=3e-40]} {Celegans: WBGene00004929, soc-2, Leucine-rich repeat protein soc-2, [Score=151, Expect=1e-38]} {Smed: dd_Smed_v6_10136_0_1, dd_Smed_v6_10136_0_1, [RH, Score=281, Expect=6e-85]} {RNA1509_11343, RNA1509_19633} {RNA1310_7039.2, RNA1509_11343} {RNA1509_11343, RNA815_1369.1} |
30. | MligTC455_05979 | 11 | 0.23 | Mlig455_067718 | Neo: - Age: - |
0.981 | - | - | - | - | 0.981 | - | Mlig455_067718 {REF} {Length: 1018} {RNA1509_2330} {RNA1310_37520} {RNA815_22367} | |
31. | MligTC455_18262 | 28 | 0.59 | Mlig455_023697 | Neo: - Age: Down-Up-Down |
0.981 | - | - | - | - | 0.981 | - | Mlig455_023697 {REF} {Length: 552} {NoTransDecoderORF} {RNA1509_11101} {RNA1310_22145} {RNA815_35811} | |
32. | MligTC455_21884 | 13 | 0.27 | Mlig455_070568 | Neo: - Age: - |
SRSF7 | 0.981 | - | - | - | - | 0.981 | - | Mlig455_070568 {REF} {Length: 1659} {TRANSSPLICED} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=59.7]; RNA recognition motif [PF16367.7, score=24.4]; Zinc knuckle [PF00098.25, score=20.7]; RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF13893.8, score=19.2]} {Human: ENSG00000115875, SRSF7, serine and arginine rich splicing factor 7, [RH, Score=142, Expect=6e-43]} {Mouse: ENSMUSG00000024097, Srsf7, serine/arginine-rich splicing factor 7, [RH, Score=142, Expect=4e-43]} {Dmel: FBgn0260944, Rbp1, RNA-binding protein 1, [RH, Score=102, Expect=2e-27]} {Celegans: WBGene00004703, rsp-6, Probable splicing factor, arginine/serine-rich 6, [Score=103, Expect=7e-28]} {Smed: dd_Smed_v6_2424_0_1, dd_Smed_v6_2424_0_1, [RH, Score=124, Expect=4e-36]} {RNA1509_38744} {RNA1310_52982} {RNA815_7835} |
33. | MligTC455_31082 | 93 | 1.93 | Mlig455_020193 | Neo: - Age: Up-Down-Up |
0.981 | - | - | - | - | 0.981 | - | Mlig455_020193 {REF} {Length: 1952} {RNA1509_54750} {RNA1310_22843} {RNA815_11564.1} | |
34. | MligTC455_13130 | 40 | 0.83 | Mlig455_032511, Mlig455_068691 | Neo: - Age: - |
WSCD2 | 0.98 | - | - | - | - | 0.980 | - | Mlig455_032511 {REF} {Length: 927} {Pfam: WSC domain [PF01822.21, score=40.9]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=50.4, Expect=6e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=50.4, Expect=4e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=60.1, Expect=2e-10]} {RNA1310_39527} {RNA815_19067} Mlig455_068691 {REF} {Length: 927} {Pfam: WSC domain [PF01822.21, score=41.8]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=50.1, Expect=1e-06]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=49.7, Expect=9e-07]; ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=47.8, Expect=4e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=62.0, Expect=6e-11]} {RNA1310_39527} {RNA815_19067} |
35. | MligTC455_24855 | 72 | 1.5 | Mlig455_044777, Mlig455_053676 | Neo: - Age: - |
0.98 | - | - | 0.980 | - | - | - | Mlig455_044777 {REF} {Length: 1840} {NoTransDecoderORF} {RNA1509_47921} {RNA1310_90646} {RNA815_8730.1} Mlig455_053676 {REF} {Length: 1840} {NoTransDecoderORF} {RNA1509_47921} {RNA1310_90646} {RNA815_8730.1} |
|
36. | MligTC455_37770 | 23 | 0.48 | Mlig455_036212 | Neo: - Age: - Region-enriched R4: 4.453/0.00702 |
0.98 | - | - | 0.980 | - | - | - | Mlig455_036212 {REF} {Length: 619} {RNA1310_55722} | |
37. | MligTC455_40989 | 801 | 16.68 | Mlig455_016294 | Neo: - Age: logFC(26M/2M)=0.270 |
PKD2 | 0.98 | - | - | - | - | 0.980 | - | Mlig455_016294 {REF} {Length: 3179} {Pfam: Polycystin cation channel [PF08016.14, score=486.5]; Ion transport protein [PF00520.33, score=90.3]; EF hand [PF00036.34, score=23.7]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=718, Expect=0.0]; ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [RH, Score=712, Expect=0.0]} {Mouse: ENSMUSG00000037578, Pkd2l1, polycystic kidney disease 2-like 1, [RH, Score=704, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=310, Expect=2e-91]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=370, Expect=7e-116]} {Smed: dd_Smed_v6_13327_0_1, dd_Smed_v6_13327_0_1, [RH, Score=743, Expect=0.0]} {RNA1509_14023, RNA1509_24240} {RNA1310_4836.1, RNA1509_14023, RNA1509_24240} {RNA1509_14023, RNA1509_24240, RNA815_4677} |
38. | MligTC455_15441 | 62 | 1.29 | Mlig455_037158 | Neo: - Age: - |
0.979 | - | - | 0.979 | - | - | - | Mlig455_037158 {REF} {Length: 2997} {Pfam: RNA repair pathway DNA polymerase beta family [PF10127.11, score=20.8]} {RNA1509_39460} {RNA1310_16073.2} {RNA815_15926} | |
39. | MligTC455_21447 | 62 | 1.29 | Mlig455_065576 | Neo: - Age: - |
0.979 | - | - | 0.979 | - | - | - | Mlig455_065576 {REF} {Length: 2023} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=29.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=26.0]} {Smed: dd_Smed_v6_27761_0_1, dd_Smed_v6_27761_0_1, [Score=64.3, Expect=4e-11]} {RNA1310_104043} | |
40. | MligTC455_48571 | 99 | 2.06 | Mlig455_068334 | Neo: - Age: - Region-enriched R2: 3.861/0.00695 |
0.979 | - | - | 0.979 | - | - | - | Mlig455_068334 {REF} {Length: 319} {RNA1509_42654} {RNA1310_10680} {RNA815_32705} | |
41. | MligTC455_13471 | 12 | 0.26 | Mlig455_065390 | Neo: - Age: - |
0.978 | - | - | - | - | 0.978 | - | Mlig455_065390 {REF} {Length: 665} {NoTransDecoderORF} {RNA1509_16969} {RNA1310_51432} {RNA815_47685} | |
42. | MligTC455_12401 | 218 | 4.54 | Mlig455_064069, Mlig455_064995 | Neo: - Age: Down-Up-Down |
PLK3 | 0.977 | - | - | 0.977 | - | - | - | Mlig455_064069 {REF} {Length: 2278} {Pfam: Protein kinase domain [PF00069.27, score=211.5]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=147.4]; Fungal protein kinase [PF17667.3, score=21.4]; Kinase-like [PF14531.8, score=21.2]; POLO box duplicated region [PF00659.20, score=20.7]} {Human: ENSG00000173846, PLK3, polo like kinase 3, [Score=205, Expect=1e-57]; ENSG00000145632, PLK2, polo like kinase 2, [Score=199, Expect=2e-55]; ENSG00000166851, PLK1, polo like kinase 1, [Score=195, Expect=2e-54]} {Mouse: ENSMUSG00000035486, Plk5, polo like kinase 5, [Score=213, Expect=3e-61]; ENSMUSG00000028680, Plk3, polo like kinase 3, [Score=207, Expect=9e-59]} {Dmel: FBgn0003124, polo, [Score=191, Expect=2e-53]} {Celegans: WBGene00004042, plk-1, Serine/threonine-protein kinase plk-1, [Score=175, Expect=3e-47]} {Smed: dd_Smed_v6_4273_0_1, dd_Smed_v6_4273_0_1, [Score=177, Expect=1e-48]} {RNA1310_14464} {RNA815_42169} Mlig455_064995 {REF} {Length: 2279} {Pfam: Protein kinase domain [PF00069.27, score=211.5]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=147.4]; Fungal protein kinase [PF17667.3, score=21.4]; Kinase-like [PF14531.8, score=21.2]; POLO box duplicated region [PF00659.20, score=20.7]} {Human: ENSG00000173846, PLK3, polo like kinase 3, [Score=205, Expect=1e-57]; ENSG00000145632, PLK2, polo like kinase 2, [Score=199, Expect=2e-55]; ENSG00000166851, PLK1, polo like kinase 1, [Score=195, Expect=2e-54]} {Mouse: ENSMUSG00000035486, Plk5, polo like kinase 5, [Score=213, Expect=3e-61]; ENSMUSG00000028680, Plk3, polo like kinase 3, [Score=207, Expect=9e-59]} {Dmel: FBgn0003124, polo, [Score=191, Expect=2e-53]} {Celegans: WBGene00004042, plk-1, Serine/threonine-protein kinase plk-1, [Score=175, Expect=3e-47]} {Smed: dd_Smed_v6_4273_0_1, dd_Smed_v6_4273_0_1, [Score=177, Expect=1e-48]} {RNA1310_14464} {RNA815_42169} |
43. | MligTC455_22853 | 33 | 0.7 | Mlig455_019405, Mlig455_059068 | Neo: - Age: - |
0.977 | - | - | - | - | 0.977 | - | Mlig455_019405 {REF} {Length: 4200} {Smed: dd_Smed_v6_3718_0_2, dd_Smed_v6_3718_0_2, [Score=66.2, Expect=9e-12]} {RNA1310_63811} Mlig455_059068 {REF} {Length: 4200} {Pfam: Integrase zinc binding domain [PF17921.3, score=58.4]; Integrase core domain [PF00665.28, score=32.8]} {Smed: dd_Smed_v6_6563_0_1, dd_Smed_v6_6563_0_1, [Score=63.5, Expect=1e-10]} {RNA1310_63811} |
|
44. | MligTC455_23938 | 109 | 2.26 | Mlig455_044682 | Neo: - Age: logFC(26M/2M)=0.355 |
TRPM3 | 0.977 | - | - | - | - | 0.977 | - | Mlig455_044682 {REF} {Length: 6333} {Pfam: Ankyrin repeats (many copies) [PF13637.8, score=80.4]; Ankyrin repeats (3 copies) [PF12796.9, score=74.8]; Ankyrin repeat [PF13606.8, score=59.5]; Ion transport protein [PF00520.33, score=57.5]; Ankyrin repeat [PF00023.32, score=51.1]; Ankyrin repeats (many copies) [PF13857.8, score=38.9]} {Human: ENSG00000083067, TRPM3, transient receptor potential cation channel subfamily M member 3, [Score=139, Expect=2e-32]; ENSG00000134160, TRPM1, transient receptor potential cation channel subfamily M member 1, [Score=139, Expect=2e-32]; ENSG00000274965, TRPM1, transient receptor potential cation channel subfamily M member 1, [Score=139, Expect=2e-32]} {Mouse: ENSMUSG00000030523, Trpm1, transient receptor potential cation channel, subfamily M, member 1, [Score=141, Expect=3e-33]; ENSMUSG00000052387, Trpm3, transient receptor potential cation channel, subfamily M, member 3, [Score=140, Expect=4e-33]} {Dmel: FBgn0265194, Trpm, Transient receptor potential cation channel, subfamily M, [Score=112, Expect=2e-24]} {Celegans: WBGene00001651, gon-2, Transient receptor potential channel, [Score=111, Expect=2e-24]} {Smed: dd_Smed_v6_8382_0_1, dd_Smed_v6_8382_0_1, [Score=192, Expect=2e-49]} {RNA1509_19611, RNA1509_32799} {RNA1310_1742.1, RNA1509_19611, RNA1509_32799} {RNA1509_19611, RNA1509_32799, RNA815_1771} |
45. | MligTC455_50649 | 91 | 1.9 | Mlig455_014003 | Neo: - |
GRM3 | 0.977 | - | - | - | 0.977 | - | - | Mlig455_014003 {REF} {Length: 4598} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=148.4]; Receptor family ligand binding region [PF01094.30, score=25.5]; Nine Cysteines Domain of family 3 GPCR [PF07562.16, score=23.6]} {Human: ENSG00000198822, GRM3, glutamate metabotropic receptor 3, [Score=243, Expect=1e-68]; ENSG00000196277, GRM7, glutamate metabotropic receptor 7, [Score=235, Expect=1e-65]; ENSG00000164082, GRM2, glutamate metabotropic receptor 2, [Score=233, Expect=3e-65]; ENSG00000179603, GRM8, glutamate metabotropic receptor 8, [Score=231, Expect=2e-64]} {Mouse: ENSMUSG00000003974, Grm3, glutamate receptor, metabotropic 3, [Score=240, Expect=7e-68]; ENSMUSG00000023192, Grm2, glutamate receptor, metabotropic 2, [Score=237, Expect=1e-66]; ENSMUSG00000024211, Grm8, glutamate receptor, metabotropic 8, [Score=236, Expect=3e-66]; ENSMUSG00000056755, Grm7, glutamate receptor, metabotropic 7, [Score=234, Expect=9e-66]} {Dmel: FBgn0050361, mtt, mangetout, [Score=273, Expect=2e-80]} {Celegans: WBGene00003232, mgl-1, Probable metabotropic glutamate receptor mgl-1, [Score=213, Expect=1e-58]} {Smed: dd_Smed_v6_10130_0_1, dd_Smed_v6_10130_0_1, [Score=290, Expect=1e-85]} {RNA1509_34817} {RNA1310_58007} {RNA815_44956} |
46. | MligTC455_06577 | 7 | 0.14 | Mlig455_044334 | Neo: - Age: Up-Down-Down |
0.976 | - | - | - | - | 0.976 | - | Mlig455_044334 {REF} {Length: 706} | |
47. | MligTC455_19695 | 59 | 1.23 | Mlig455_067848 | Neo: - Age: logFC(26M/2M)=-0.595 |
0.976 | - | - | - | - | 0.976 | - | Mlig455_067848 {REF} {Length: 1979} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=32.9]} {Smed: dd_Smed_v6_12148_0_3, dd_Smed_v6_12148_0_3, [Score=76.3, Expect=8e-16]} {RNA1509_37281} {RNA1310_6533.1} {RNA815_6407} | |
48. | MligTC455_23029 | 200 | 4.16 | Mlig455_043356 | Neo: - Age: Up-Down-Down Region-enriched R2: 2.584/0.02978 |
ABL1 | 0.976 | - | - | 0.976 | - | - | - | Mlig455_043356 {REF} {Length: 5848} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=320.1]; Protein kinase domain [PF00069.27, score=153.7]; SH2 domain [PF00017.26, score=78.5]; F-actin binding [PF08919.12, score=34.5]; Variant SH3 domain [PF14604.8, score=20.6]; SH3 domain [PF00018.30, score=18.8]} {Human: ENSG00000097007, ABL1, ABL proto-oncogene 1, non-receptor tyrosine kinase, [RH, Score=548, Expect=1e-176]; ENSG00000143322, ABL2, ABL proto-oncogene 2, non-receptor tyrosine kinase, [RH, Score=543, Expect=3e-174]} {Mouse: ENSMUSG00000026842, Abl1, c-abl oncogene 1, non-receptor tyrosine kinase, [RH, Score=549, Expect=2e-177]; ENSMUSG00000026596, Abl2, v-abl Abelson murine leukemia viral oncogene 2 (arg, Abelson-related gene), [RH, Score=538, Expect=9e-174]} {Dmel: FBgn0000017, Abl, Abl tyrosine kinase, [RH, Score=548, Expect=3e-172]} {Celegans: WBGene00000018, abl-1, Tyrosine-protein kinase abl-1, [RH, Score=517, Expect=2e-164]} {Smed: dd_Smed_v6_4352_0_1, dd_Smed_v6_4352_0_1, [RH, Score=555, Expect=0.0]} {RNA1509_21216, RNA1509_50452} {RNA1310_7858, RNA1509_50452} {RNA1509_50452, RNA815_21818} |
49. | MligTC455_10204 | 14 | 0.29 | Mlig455_049702, Mlig455_049708 | Neo: - Age: - |
0.975 | - | - | - | - | 0.975 | - | Mlig455_049702 {REF} {Length: 217} {NoTransDecoderORF} {RNA1509_48455} {RNA1310_47324} {RNA815_43123} Mlig455_049708 {REF} {Length: 443} {NoTransDecoderORF} {RNA1509_48455} {RNA1310_57782} {RNA815_43123} |
|
50. | MligTC455_48125 | 91 | 1.9 | Mlig455_005602, Mlig455_070397 | Neo: - Age: - Region-enriched R2: 4.171/0.01740 |
0.975 | - | - | - | - | 0.975 | - | Mlig455_005602 {REF} {Length: 2407} {RNA1509_6760} {RNA1310_2628} {RNA815_4402} Mlig455_070397 {REF} {Length: 2447} {RNA1509_6760} {RNA1310_132399} {RNA815_4402} |
|
51. | MligTC455_19356 | 231 | 4.82 | Mlig455_014575 | Neo: - Age: - |
0.974 | - | - | - | 0.974 | - | - | Mlig455_014575 {REF} {Length: 2375} {Pfam: Tetraspanin family [PF00335.22, score=48.8]} {RNA1509_19196, RNA1509_4200} {RNA1310_51568.1, RNA1509_19196, RNA1509_4200} {RNA1509_19196, RNA1509_4200, RNA815_5900.4} | |
52. | MligTC455_20571 | 72 | 1.5 | Mlig455_016577, Mlig455_035609 | Neo: - |
IRX6 | 0.974 | - | - | - | - | 0.974 | - | Mlig455_016577 {REF} {Length: 1698} {Pfam: Homeobox KN domain [PF05920.13, score=52.1]; Homeodomain [PF00046.31, score=26.8]} {Human: ENSG00000159387, IRX6, iroquois homeobox 6, [Score=127, Expect=4e-33]; ENSG00000170561, IRX2, iroquois homeobox 2, [Score=121, Expect=6e-31]} {Mouse: ENSMUSG00000031738, Irx6, Iroquois homeobox 6, [Score=123, Expect=8e-32]; ENSMUSG00000001504, Irx2, Iroquois homeobox 2, [Score=121, Expect=5e-31]; ENSMUSG00000031737, Irx5, Iroquois homeobox 5, [Score=120, Expect=1e-30]; ENSMUSG00000021604, Irx4, Iroquois homeobox 4, [Score=118, Expect=1e-29]; ENSMUSG00000031734, Irx3, Iroquois related homeobox 3, [Score=117, Expect=2e-29]} {Dmel: FBgn0015904, ara, araucan, [Score=122, Expect=7e-31]} {Celegans: WBGene00007984, irx-1, Putative iroquois-class homeodomain protein irx-1, [Score=107, Expect=1e-26]} {Smed: dd_Smed_v6_17352_0_1, dd_Smed_v6_17352_0_1, [Score=129, Expect=9e-35]} {RNA1509_32988} {RNA1310_38999} {RNA815_42442} Mlig455_035609 {REF} {Length: 3012} {Pfam: Homeobox KN domain [PF05920.13, score=52.1]; Homeodomain [PF00046.31, score=26.8]} {Human: ENSG00000159387, IRX6, iroquois homeobox 6, [Score=125, Expect=1e-32]; ENSG00000170561, IRX2, iroquois homeobox 2, [Score=120, Expect=1e-30]; ENSG00000176842, IRX5, iroquois homeobox 5, [Score=119, Expect=4e-30]} {Mouse: ENSMUSG00000031738, Irx6, Iroquois homeobox 6, [Score=122, Expect=2e-31]; ENSMUSG00000001504, Irx2, Iroquois homeobox 2, [Score=120, Expect=1e-30]; ENSMUSG00000031737, Irx5, Iroquois homeobox 5, [Score=119, Expect=3e-30]; ENSMUSG00000021604, Irx4, Iroquois homeobox 4, [Score=117, Expect=2e-29]; ENSMUSG00000031734, Irx3, Iroquois related homeobox 3, [Score=116, Expect=3e-29]} {Dmel: FBgn0015904, ara, araucan, [Score=121, Expect=1e-30]} {Celegans: WBGene00007984, irx-1, Putative iroquois-class homeodomain protein irx-1, [Score=107, Expect=2e-26]} {Smed: dd_Smed_v6_17352_0_1, dd_Smed_v6_17352_0_1, [Score=129, Expect=1e-34]} {RNA1509_32988} {RNA1310_38999} {RNA815_42442} |
53. | MligTC455_24786 | 300 | 6.25 | Mlig455_032143, Mlig455_049302 | Neo: - Age: logFC(26M/2M)=-0.528 |
0.974 | - | - | - | - | 0.974 | - | Mlig455_032143 {REF} {Length: 358} {NoTransDecoderORF} {RNA1509_36687} {RNA1310_1894} {RNA815_5614.1} Mlig455_049302 {REF} {Length: 3378} {Pfam: PT repeat [PF04886.14, score=51.8]} {RNA1509_45844} {RNA1310_12902.2} {RNA815_515.1} |
|
54. | MligTC455_31210 | 51 | 1.07 | Mlig455_028581 | Neo: - Age: Down-Up-Down |
KCNH7 | 0.973 | - | - | - | - | 0.973 | - | Mlig455_028581 {REF} {Length: 6310} {Pfam: Ion transport protein [PF00520.33, score=119.1]; PAS domain [PF13426.9, score=52.9]; Ion channel [PF07885.18, score=45.3]; Cyclic nucleotide-binding domain [PF00027.31, score=45.2]; PAS fold [PF00989.27, score=31.5]; PAS fold [PF08447.14, score=26.5]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [RH, Score=820, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [RH, Score=810, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [RH, Score=808, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [RH, Score=820, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [RH, Score=808, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [RH, Score=806, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [RH, Score=766, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [RH, Score=746, Expect=0.0]} {Smed: dd_Smed_v6_12621_0_1, dd_Smed_v6_12621_0_1, [Score=793, Expect=0.0]} {RNA1509_40124} {RNA1310_20497} {RNA815_15478} |
55. | MligTC455_09822 | 5 | 0.1 | Mlig455_017858 | Neo: - Age: - |
0.972 | - | - | - | - | 0.972 | - | Mlig455_017858 {REF} {Length: 616} {NoTransDecoderORF} {RNA1310_73710} | |
56. | MligTC455_17534 | 40 | 0.84 | Mlig455_004568 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.609/0.04169 |
0.972 | - | - | - | - | 0.972 | - | Mlig455_004568 {REF} {Length: 2000} {Pfam: CD20-like family [PF04103.17, score=25.6]} {RNA1509_45188} {RNA1310_19605, RNA1509_45188} {RNA1509_45188, RNA815_13393} | |
57. | MligTC455_36543 | 145 | 3.03 | Mlig455_067860 | Neo: - Age: Down-Up-Up |
MFSD8 | 0.972 | - | - | 0.972 | - | - | - | Mlig455_067860 {REF} {Length: 3751} {Pfam: Major Facilitator Superfamily [PF07690.18, score=87.6]} {Human: ENSG00000164073, MFSD8, major facilitator superfamily domain containing 8, [Score=61.2, Expect=2e-09]} {Mouse: ENSMUSG00000116169, Mfsd8, major facilitator superfamily domain containing 8, [Score=58.2, Expect=2e-09]; ENSMUSG00000025759, Mfsd8, major facilitator superfamily domain containing 8, [Score=58.2, Expect=2e-09]} {Smed: dd_Smed_v6_9883_0_1, dd_Smed_v6_9883_0_1, [RH, Score=369, Expect=7e-123]} {RNA1509_54938} {RNA1310_19930} {RNA815_20915} |
58. | MligTC455_49214 | 6 | 0.13 | Mlig455_068565 | Neo: - Age: - |
0.972 | - | - | - | - | 0.972 | - | Mlig455_068565 {REF} {Length: 1544} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=105.5]} {Smed: dd_Smed_v6_26469_0_1, dd_Smed_v6_26469_0_1, [Score=53.1, Expect=3e-08]} {RNA1310_27155} {RNA815_39321} | |
59. | MligTC455_00072 | 10 | 0.2 | Mlig455_001911 | Neo: - Age: - |
0.971 | - | - | - | - | 0.971 | - | Mlig455_001911 {REF} {Length: 296} {NoTransDecoderORF} {RNA1310_118235} | |
60. | MligTC455_29464 | 25 | 0.53 | Mlig455_021892 | Neo: - Age: - |
SDCCAG8 | 0.971 | - | - | - | - | 0.971 | - | Mlig455_021892 {REF} {Length: 3036} {Pfam: Centrosomal colon cancer autoantigen protein family [PF15964.7, score=164.7]} {Human: ENSG00000276111, SDCCAG8, serologically defined colon cancer antigen 8, [RH, Score=120, Expect=2e-27]; ENSG00000054282, SDCCAG8, serologically defined colon cancer antigen 8, [RH, Score=120, Expect=2e-27]} {Mouse: ENSMUSG00000026504, Sdccag8, serologically defined colon cancer antigen 8, [RH, Score=109, Expect=4e-24]} {Dmel: FBgn0266566, CG45105, [Score=52.4, Expect=2e-06]} {Smed: dd_Smed_v6_9295_0_2, dd_Smed_v6_9295_0_2, [RH, Score=87.8, Expect=7e-18]} {RNA1509_42574} {RNA1310_5942.1} {RNA815_9353.1} |
61. | MligTC455_33004 | 291 | 6.07 | Mlig455_035954, Mlig455_058423 | Neo: - Age: Down-Up-Up Region-enriched R8: 3.765/0.00001 |
LRP12 | 0.971 | - | - | 0.971 | - | - | - | Mlig455_035954 {REF} {Length: 2125} {Pfam: Low-density lipoprotein receptor domain class A [PF00057.20, score=37.1]} {Human: ENSG00000147650, LRP12, LDL receptor related protein 12, [Score=49.3, Expect=3e-06]; ENSG00000171208, NETO2, neuropilin and tolloid like 2, [Score=47.4, Expect=1e-05]} {Mouse: ENSMUSG00000022305, Lrp12, low density lipoprotein-related protein 12, [Score=49.7, Expect=2e-06]} {RNA1509_18736} {RNA1310_23783.1} {RNA815_18491} Mlig455_058423 {REF} {Length: 1426} {Pfam: Low-density lipoprotein receptor domain class A [PF00057.20, score=37.1]} {Human: ENSG00000147650, LRP12, LDL receptor related protein 12, [Score=49.3, Expect=3e-06]; ENSG00000171208, NETO2, neuropilin and tolloid like 2, [Score=48.5, Expect=6e-06]} {Mouse: ENSMUSG00000022305, Lrp12, low density lipoprotein-related protein 12, [Score=49.7, Expect=2e-06]; ENSMUSG00000036902, Neto2, neuropilin (NRP) and tolloid (TLL)-like 2, [Score=48.5, Expect=4e-06]} {RNA1310_23783.1} {RNA815_18491} |
62. | MligTC455_44444 | 123 | 2.57 | Mlig455_062758 | Neo: - Age: - |
0.971 | - | - | - | - | 0.971 | - | Mlig455_062758 {REF} {Length: 1304} {Pfam: Retinal tissue protein [PF10044.11, score=28.1]} {RNA1509_3524} {RNA1310_10649.1} {RNA815_4708.1} | |
63. | MligTC455_14583 | 33 | 0.69 | Mlig455_008303, Mlig455_008334 | Neo: - Age: - |
ADAM33, ADAM9 | 0.97 | - | - | - | 0.970 | - | - | Mlig455_008303 {REF} {Length: 2620} {Pfam: Reprolysin (M12B) family zinc metalloprotease [PF01421.21, score=143.0]; Metallo-peptidase family M12 [PF13688.8, score=76.4]; Disintegrin [PF00200.25, score=72.2]; Metallo-peptidase family M12B Reprolysin-like [PF13582.8, score=45.7]; ADAM cysteine-rich [PF08516.14, score=45.0]; Metallo-peptidase family M12B Reprolysin-like [PF13574.8, score=41.2]; Metallo-peptidase family M12B Reprolysin-like [PF13583.8, score=37.2]} {Human: ENSG00000168615, ADAM9, ADAM metallopeptidase domain 9, [Score=249, Expect=1e-71]; ENSG00000148848, ADAM12, ADAM metallopeptidase domain 12, [Score=242, Expect=7e-68]} {Mouse: ENSMUSG00000031555, Adam9, a disintegrin and metallopeptidase domain 9 (meltrin gamma), [Score=258, Expect=4e-74]} {Dmel: FBgn0265140, Meltrin, [Score=273, Expect=1e-78]} {Celegans: WBGene00000074, adm-2, ADAM (Disintegrin plus metalloprotease) family, [Score=233, Expect=6e-65]} {Smed: dd_Smed_v6_5143_0_1, dd_Smed_v6_5143_0_1, [Score=201, Expect=1e-53]} {RNA1509_45880} {RNA1310_77182} {RNA815_37786} Mlig455_008334 {REF} {Length: 2763} {Pfam: Reprolysin (M12B) family zinc metalloprotease [PF01421.21, score=125.2]; Disintegrin [PF00200.25, score=72.6]; Metallo-peptidase family M12 [PF13688.8, score=64.4]; Metallo-peptidase family M12B Reprolysin-like [PF13582.8, score=46.3]; ADAM cysteine-rich [PF08516.14, score=44.9]; Metallo-peptidase family M12B Reprolysin-like [PF13574.8, score=40.6]; Metallo-peptidase family M12B Reprolysin-like [PF13583.8, score=32.8]} {Human: ENSG00000149451, ADAM33, ADAM metallopeptidase domain 33, [Score=224, Expect=4e-63]; ENSG00000168615, ADAM9, ADAM metallopeptidase domain 9, [Score=221, Expect=1e-62]; ENSG00000148848, ADAM12, ADAM metallopeptidase domain 12, [Score=219, Expect=7e-61]; ENSG00000134007, ADAM20, ADAM metallopeptidase domain 20, [Score=216, Expect=2e-60]; ENSG00000143537, ADAM15, ADAM metallopeptidase domain 15, [Score=215, Expect=5e-60]} {Mouse: ENSMUSG00000031555, Adam9, a disintegrin and metallopeptidase domain 9 (meltrin gamma), [Score=229, Expect=6e-65]; ENSMUSG00000054555, Adam12, a disintegrin and metallopeptidase domain 12 (meltrin alpha), [Score=221, Expect=5e-62]; ENSMUSG00000025473, Adam8, a disintegrin and metallopeptidase domain 8, [Score=219, Expect=6e-62]} {Dmel: FBgn0265140, Meltrin, [Score=247, Expect=7e-71]} {Celegans: WBGene00000074, adm-2, ADAM (Disintegrin plus metalloprotease) family, [Score=218, Expect=7e-61]} {Smed: dd_Smed_v6_5143_0_1, dd_Smed_v6_5143_0_1, [Score=194, Expect=2e-52]} {RNA1509_45880} {RNA1310_77182} {RNA815_1440.1} |
64. | MligTC455_17427 | 37 | 0.77 | Mlig455_047879 | Neo: - Age: - |
0.97 | - | - | 0.970 | - | - | - | Mlig455_047879 {REF} {Length: 4230} {RNA1509_52053} {RNA1310_13207} {RNA815_25004} | |
65. | MligTC455_25410 | 47 | 0.97 | Mlig455_026185 | Neo: - Age: Up-Down-Down Region-enriched R2: 8.036/0.00469 |
0.97 | - | - | - | - | 0.970 | - | Mlig455_026185 {REF} {Length: 3002} {Pfam: Variant SH3 domain [PF07653.19, score=19.6]; Growth-arrest specific micro-tubule binding [PF13851.8, score=19.3]} {Mouse: ENSMUSG00000034156, Tspoap1, TSPO associated protein 1, [Score=54.7, Expect=6e-07]} {Smed: dd_Smed_v6_14584_0_1, dd_Smed_v6_14584_0_1, [Score=140, Expect=7e-35]} {RNA1509_45271} {RNA1310_5741} {RNA815_46868} | |
66. | MligTC455_13046 | 94 | 1.96 | Mlig455_027003, Mlig455_043462 | Neo: - Age: - |
0.969 | - | - | 0.969 | - | - | - | Mlig455_027003 {REF} {Length: 2071} {NoTransDecoderORF} {RNA1509_31427} {RNA1310_20953.1} {RNA815_18897.1} Mlig455_043462 {REF} {Length: 746} {NoTransDecoderORF} {RNA1310_97651} |
|
67. | MligTC455_36981 | 59 | 1.23 | Mlig455_050314 | Neo: - Age: - Region-enriched R2: 4.760/0.03524 |
ASIC5 | 0.969 | - | - | 0.969 | - | - | - | Mlig455_050314 {REF} {Length: 3328} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=158.3]; Kringle domain [PF00051.20, score=20.5]} {Human: ENSG00000256394, ASIC5, acid sensing ion channel subunit family member 5, [Score=59.3, Expect=2e-08]} {Mouse: ENSMUSG00000028008, Asic5, acid-sensing (proton-gated) ion channel family member 5, [Score=51.6, Expect=3e-06]} {Smed: dd_Smed_v6_16557_0_1, dd_Smed_v6_16557_0_1, [Score=52.8, Expect=6e-07]} {RNA1310_9846.1} {RNA815_21595} |
68. | MligTC455_40204 | 348 | 7.24 | Mlig455_064913, Mlig455_066843 | Neo: - Age: logFC(26M/2M)=-0.350 |
0.969 | - | - | - | - | 0.969 | - | Mlig455_064913 {REF} {Length: 1143} {NoTransDecoderORF} {RNA1509_52747} {RNA1310_89294} {RNA815_41786} Mlig455_066843 {REF} {Length: 633} {NoTransDecoderORF} {RNA1310_106751} {RNA815_41786} |
|
69. | MligTC455_47244 | 216 | 4.49 | Mlig455_016130 | Neo: - Age: - Region-enriched R2: 3.391/0.02151 |
0.969 | - | - | - | - | 0.969 | - | Mlig455_016130 {REF} {Length: 3312} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=27.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=20.5]} {Smed: dd_Smed_v6_24733_0_1, dd_Smed_v6_24733_0_1, [RH, Score=231, Expect=1e-71]} {RNA1509_41111} {RNA1310_18481.1} {RNA815_10445} | |
70. | MligTC455_51200 | 66 | 1.37 | Mlig455_057090 | Neo: - Age: - |
0.969 | - | - | - | - | 0.969 | - | Mlig455_057090 {REF} {Length: 988} {RNA1310_63663} {RNA815_36272} | |
71. | MligTC455_54035 | 84 | 1.74 | Mlig455_017217 | Neo: - Age: Down-Up-Down |
CALML5 | 0.969 | - | - | 0.969 | - | - | - | Mlig455_017217 {REF} {Length: 1760} {Pfam: EF hand [PF00036.34, score=48.2]; EF-hand domain pair [PF13499.8, score=45.0]; EF-hand domain [PF13405.8, score=40.7]; EF hand [PF13202.8, score=34.7]; EF-hand domain pair [PF13833.8, score=29.2]} {Human: ENSG00000178372, CALML5, calmodulin like 5, [Score=50.4, Expect=7e-08]} {Mouse: ENSMUSG00000097733, Cabp2, calcium binding protein 2, [Score=45.8, Expect=5e-06]; ENSMUSG00000024857, Cabp2, calcium binding protein 2, [Score=45.8, Expect=5e-06]} {Celegans: WBGene00000287, cal-3, CALmodulin related genes, [Score=50.4, Expect=7e-08]} {Smed: dd_Smed_v6_4512_0_1, dd_Smed_v6_4512_0_1, [Score=45.8, Expect=2e-06]} {RNA1509_44750} {RNA1310_71381} {RNA815_19875} |
72. | MligTC455_03038 | 227 | 4.72 | Mlig455_060778 | Neo: - Age: Down-Up-Down Region-enriched R8: 6.261/0.00000 |
0.968 | - | - | 0.968 | - | - | - | Mlig455_060778 {REF} {Length: 4155} {TRANSSPLICED} {tRNA: Val(CAC),pseudo, score=27.8} {Mouse: ENSMUSG00000059854, Hydin, HYDIN, axonemal central pair apparatus protein, [Score=55.1, Expect=5e-07]} {RNA1509_16236} {RNA1310_4008} {RNA815_2550} | |
73. | MligTC455_24515 | 14 | 0.28 | Mlig455_033346, Mlig455_033365 | Neo: - Age: - |
HTR1B | 0.968 | - | - | - | - | 0.968 | - | Mlig455_033346 {REF} {Length: 1493} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=216.8]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=27.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=23.5]} {Human: ENSG00000135312, HTR1B, 5-hydroxytryptamine receptor 1B, [Score=211, Expect=4e-63]} {Mouse: ENSMUSG00000021478, Drd1, dopamine receptor D1, [RH, Score=189, Expect=2e-54]} {Dmel: FBgn0004573, 5-HT7, 5-hydroxytryptamine (serotonin) receptor 7, [Score=182, Expect=7e-51]} {Celegans: WBGene00001052, dop-1, DOPamine receptor, [Score=176, Expect=4e-50]} {Smed: dd_Smed_v6_26479_0_1, dd_Smed_v6_26479_0_1, [Score=218, Expect=5e-66]} {RNA1310_132724} Mlig455_033365 {REF} {Length: 1935} {TRANSSPLICED} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=216.2]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=25.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=24.0]} {Human: ENSG00000135312, HTR1B, 5-hydroxytryptamine receptor 1B, [Score=211, Expect=7e-63]} {Mouse: ENSMUSG00000021478, Drd1, dopamine receptor D1, [RH, Score=191, Expect=4e-55]} {Dmel: FBgn0004573, 5-HT7, 5-hydroxytryptamine (serotonin) receptor 7, [Score=182, Expect=7e-51]} {Celegans: WBGene00001052, dop-1, DOPamine receptor, [Score=178, Expect=8e-51]} {Smed: dd_Smed_v6_26479_0_1, dd_Smed_v6_26479_0_1, [Score=216, Expect=2e-65]} {RNA1310_132724} |
74. | MligTC455_36038 | 63 | 1.32 | Mlig455_015965 | Neo: - |
0.968 | - | - | 0.968 | - | - | - | Mlig455_015965 {REF} {Length: 2113} {Pfam: Crescentin protein [PF19220.2, score=18.6]; Filament-like plant protein, long coiled-coil [PF05911.13, score=18.1]} {RNA1310_31643} {RNA815_23345} | |
75. | MligTC455_09794 | 47 | 0.98 | Mlig455_039192 | Neo: - Age: - Region-enriched R2: 4.286/0.04353 |
AKTIP | 0.967 | - | - | 0.967 | - | - | - | Mlig455_039192 {REF} {Length: 2085} {TRANSSPLICED} {Pfam: Ubiquitin-conjugating enzyme [PF00179.28, score=32.1]} {Human: ENSG00000166971, AKTIP, AKT interacting protein, [RH, Score=106, Expect=2e-26]} {Mouse: ENSMUSG00000031667, Aktip, thymoma viral proto-oncogene 1 interacting protein, [RH, Score=107, Expect=5e-27]} {Dmel: FBgn0285962, CG46338, [RH, Score=88.2, Expect=3e-20]} {Celegans: WBGene00006714, ubc-19, UBiquitin Conjugating enzyme, [RH, Score=88.2, Expect=4e-20]} {Smed: dd_Smed_v6_3423_0_1, dd_Smed_v6_3423_0_1, [RH, Score=88.2, Expect=1e-20]} {RNA1310_39420.1} {RNA815_30132} |
76. | MligTC455_32222 | 6 | 0.13 | Mlig455_068777 | Neo: - Age: Down-Up-Down |
0.967 | - | - | - | - | 0.967 | - | Mlig455_068777 {REF} {Length: 1563} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=38.2]} {Smed: dd_Smed_v6_31564_0_1, dd_Smed_v6_31564_0_1, [Score=55.5, Expect=1e-08]} {RNA1509_41917} {RNA1310_24082} {RNA815_13028} | |
77. | MligTC455_36404 | 165 | 3.45 | Mlig455_047919 | Neo: - Age: Down-Up-Down |
MRPL48 | 0.967 | - | - | 0.967 | - | - | - | Mlig455_047919 {REF} {Length: 1883} {TRANSSPLICED} {Pfam: Ribosomal protein S10p/S20e [PF00338.24, score=45.7]} {Human: ENSG00000175581, MRPL48, mitochondrial ribosomal protein L48, [RH, Score=52.4, Expect=5e-08]} {Mouse: ENSMUSG00000030706, Mrpl48, mitochondrial ribosomal protein L48, [RH, Score=48.1, Expect=9e-07]} {Dmel: FBgn0031357, mRpL48, mitochondrial ribosomal protein L48, [RH, Score=80.5, Expect=5e-19]} {Smed: dd_Smed_v6_4587_0_1, dd_Smed_v6_4587_0_1, [RH, Score=73.9, Expect=1e-16]} {RNA1509_18137, RNA1509_51510} {RNA1310_41454, RNA1509_18137, RNA1509_51510} {RNA1509_18137, RNA1509_51510, RNA815_12402} |
78. | MligTC455_53286 | 6 | 0.13 | Mlig455_061308 | Neo: - Age: - |
0.967 | - | - | - | - | 0.967 | - | Mlig455_061308 {REF} {Length: 398} {NoTransDecoderORF} | |
79. | MligTC455_12281 | 83 | 1.74 | Mlig455_014532 | Neo: - Age: - |
0.966 | - | - | 0.966 | - | - | - | Mlig455_014532 {REF} {Length: 718} {Pfam: DDE superfamily endonuclease [PF13359.8, score=26.4]} {RNA1509_49619} {RNA1310_9836} {RNA815_36431} | |
80. | MligTC455_14124 | 9 | 0.19 | Mlig455_004227, Mlig455_031052, Mlig455_031059 | Neo: - |
OTOGL, SSPO | 0.966 | - | - | - | - | 0.966 | - | Mlig455_004227 {REF} {Length: 8347} {Pfam: von Willebrand factor type D domain [PF00094.27, score=218.9]; C8 domain [PF08742.13, score=94.5]; Low-density lipoprotein receptor domain class A [PF00057.20, score=62.7]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=52.1]} {Human: ENSG00000197558, SSPO, SCO-spondin, [Score=506, Expect=2e-143]} {Mouse: ENSMUSG00000029797, Sspo, SCO-spondin, [Score=499, Expect=2e-141]} {Dmel: FBgn0029167, Hml, Hemolectin, [Score=327, Expect=5e-89]} {Celegans: WBGene00020481, T13C2.6, [Score=107, Expect=5e-23]} {Smed: dd_Smed_v6_9342_0_1, dd_Smed_v6_9342_0_1, [Score=1126, Expect=0.0]} {RNA1509_11979, RNA1509_44751} {RNA1310_598, RNA1509_44751} {RNA1509_44751, RNA815_582} Mlig455_031052 {REF} {Length: 3393} {Pfam: von Willebrand factor type D domain [PF00094.27, score=117.0]; C8 domain [PF08742.13, score=60.4]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=40.8]} {Human: ENSG00000165899, OTOGL, otogelin like, [Score=200, Expect=1e-51]} {Mouse: ENSMUSG00000001930, Vwf, Von Willebrand factor, [Score=200, Expect=8e-52]; ENSMUSG00000091455, Otogl, otogelin-like, [Score=196, Expect=1e-50]} {Dmel: FBgn0029167, Hml, Hemolectin, [Score=149, Expect=4e-36]} {Smed: dd_Smed_v6_9342_0_1, dd_Smed_v6_9342_0_1, [Score=497, Expect=7e-154]} {RNA1509_47011} {RNA1310_598} {RNA815_582} Mlig455_031059 {REF} {Length: 5292} {Pfam: von Willebrand factor type D domain [PF00094.27, score=221.4]; C8 domain [PF08742.13, score=99.8]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=55.1]; Low-density lipoprotein receptor domain class A [PF00057.20, score=52.2]} {Human: ENSG00000197558, SSPO, SCO-spondin, [Score=489, Expect=4e-142]} {Mouse: ENSMUSG00000029797, Sspo, SCO-spondin, [Score=488, Expect=6e-142]} {Dmel: FBgn0029167, Hml, Hemolectin, [Score=322, Expect=1e-88]} {Celegans: WBGene00003071, lrp-1, Low-density lipoprotein receptor-related protein, [Score=74.7, Expect=6e-13]} {Smed: dd_Smed_v6_9342_0_1, dd_Smed_v6_9342_0_1, [Score=1061, Expect=0.0]} {RNA1509_47011} {RNA1310_598} {RNA815_582} |
81. | MligTC455_19888 | 22 | 0.46 | Mlig455_066525 | Neo: - Age: - |
AC254952.1 | 0.966 | - | - | - | - | 0.966 | - | Mlig455_066525 {REF} {Length: 1890} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=188.2]; Unstructured region C-term to UIM in Ataxin3 [PF16619.7, score=20.4]} {Human: ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=188, Expect=3e-55]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=188, Expect=3e-55]; ENSG00000166664, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=188, Expect=5e-57]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=188, Expect=3e-55]; ENSG00000275917, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=185, Expect=4e-56]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=195, Expect=4e-58]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=242, Expect=1e-75]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=175, Expect=7e-51]} {Smed: dd_Smed_v6_12182_0_1, dd_Smed_v6_12182_0_1, [Score=228, Expect=9e-71]} {RNA1310_34222.1} {RNA815_33884} |
82. | MligTC455_35325 | 26 | 0.54 | Mlig455_008452, Mlig455_031353, Mlig455_056519 | Neo: - Age: - |
HTR3A | 0.966 | - | - | - | - | 0.966 | - | Mlig455_008452 {REF} {Length: 1552} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=81.9]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=26.8]} {Human: ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=97.4, Expect=2e-22]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=92.8, Expect=1e-20]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=92.8, Expect=6e-21]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=91.7, Expect=2e-20]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=90.9, Expect=3e-20]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=93.2, Expect=4e-21]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=98.2, Expect=6e-23]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=88.6, Expect=9e-20]} {RNA1509_7752} {RNA1310_93708} {RNA815_49010} Mlig455_031353 {REF} {Length: 1802} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=61.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=54.4]} {Human: ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=103, Expect=5e-25]; ENSG00000149305, HTR3B, 5-hydroxytryptamine receptor 3B, [Score=101, Expect=1e-24]} {Mouse: ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=100, Expect=4e-24]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=98.2, Expect=2e-23]; ENSMUSG00000008590, Htr3b, 5-hydroxytryptamine (serotonin) receptor 3B, [Score=96.3, Expect=7e-23]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=93.6, Expect=6e-22]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=100, Expect=1e-24]} {Smed: dd_Smed_v6_11955_0_1, dd_Smed_v6_11955_0_1, [Score=90.5, Expect=5e-21]} {RNA1509_7752} {RNA1310_93708} {RNA815_49010} Mlig455_056519 {REF} {Length: 1867} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=81.9]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=26.8]} {Human: ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=97.4, Expect=2e-22]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=92.8, Expect=1e-20]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=92.8, Expect=6e-21]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=91.7, Expect=2e-20]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=90.9, Expect=3e-20]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=93.2, Expect=4e-21]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=98.2, Expect=6e-23]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=88.6, Expect=9e-20]} {RNA1509_53098} {RNA1310_93708} {RNA815_49010} |
83. | MligTC455_40069 | 29 | 0.6 | Mlig455_069962 | Neo: - Age: - |
CHRM4 | 0.966 | - | - | 0.966 | - | - | - | Mlig455_069962 {REF} {Length: 3350} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=235.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=71.2]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=33.4]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=24.0]} {Human: ENSG00000180720, CHRM4, cholinergic receptor muscarinic 4, [Score=151, Expect=1e-38]; ENSG00000168539, CHRM1, cholinergic receptor muscarinic 1, [Score=151, Expect=8e-39]; ENSG00000184984, CHRM5, cholinergic receptor muscarinic 5, [Score=150, Expect=7e-38]; ENSG00000181072, CHRM2, cholinergic receptor muscarinic 2, [Score=147, Expect=2e-37]; ENSG00000133019, CHRM3, cholinergic receptor muscarinic 3, [Score=147, Expect=1e-36]} {Mouse: ENSMUSG00000032773, Chrm1, cholinergic receptor, muscarinic 1, CNS, [Score=152, Expect=5e-39]; ENSMUSG00000040495, Chrm4, cholinergic receptor, muscarinic 4, [Score=152, Expect=5e-39]; ENSMUSG00000045613, Chrm2, cholinergic receptor, muscarinic 2, cardiac, [Score=149, Expect=4e-38]; ENSMUSG00000074939, Chrm5, cholinergic receptor, muscarinic 5, [Score=149, Expect=2e-37]; ENSMUSG00000046159, Chrm3, cholinergic receptor, muscarinic 3, cardiac, [Score=147, Expect=8e-37]} {Dmel: FBgn0037546, mAChR-B, muscarinic Acetylcholine Receptor, B-type, [RH, Score=233, Expect=3e-64]} {Celegans: WBGene00001518, gar-2, Probable muscarinic acetylcholine receptor gar-2, [RH, Score=189, Expect=1e-54]} {Smed: dd_Smed_v6_13962_0_1, dd_Smed_v6_13962_0_1, [RH, Score=317, Expect=3e-97]} {RNA1310_44335} {RNA815_48112} |
84. | MligTC455_42708 | 48 | 1.01 | Mlig455_027999, Mlig455_028026 | Neo: - Age: - |
0.966 | - | - | - | - | 0.966 | - | Mlig455_027999 {REF} {Length: 305} {NoTransDecoderORF} {RNA1509_12495} {RNA1310_13267.2} {RNA815_40552} Mlig455_028026 {REF} {Length: 305} {NoTransDecoderORF} {RNA1509_12495} {RNA1310_13267.2} {RNA815_40552} |
|
85. | MligTC455_08911 | 45 | 0.94 | Mlig455_034546, Mlig455_064818 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.958/0.00652 |
0.964 | - | - | 0.964 | - | - | - | Mlig455_034546 {REF} {Length: 510} {RNA1310_82673} Mlig455_064818 {REF} {Length: 2324} {RNA1310_63036} |
|
86. | MligTC455_12187 | 171 | 3.55 | Mlig455_035674 | Neo: - Age: logFC(26M/2M)=0.689 |
HSD17B8 | 0.964 | - | - | 0.964 | - | - | - | Mlig455_035674 {REF} {Length: 2526} {Pfam: Enoyl-(Acyl carrier protein) reductase [PF13561.8, score=170.4]; short chain dehydrogenase [PF00106.27, score=131.4]; KR domain [PF08659.12, score=29.1]} {Human: ENSG00000112474, HSD17B8, hydroxysteroid 17-beta dehydrogenase 8, [RH, Score=105, Expect=6e-26]; ENSG00000228357, HSD17B8, hydroxysteroid 17-beta dehydrogenase 8, [RH, Score=105, Expect=6e-26]; ENSG00000232357, HSD17B8, hydroxysteroid 17-beta dehydrogenase 8, [RH, Score=105, Expect=6e-26]; ENSG00000204228, HSD17B8, hydroxysteroid 17-beta dehydrogenase 8, [RH, Score=105, Expect=6e-26]; ENSG00000228712, HSD17B8, hydroxysteroid 17-beta dehydrogenase 8, [RH, Score=105, Expect=6e-26]; ENSG00000225312, HSD17B8, hydroxysteroid 17-beta dehydrogenase 8, [RH, Score=105, Expect=6e-26]} {Mouse: ENSMUSG00000030825, Hsd17b14, hydroxysteroid (17-beta) dehydrogenase 14, [Score=123, Expect=1e-32]} {Dmel: FBgn0040349, CG3699, [Score=109, Expect=6e-28]} {Celegans: WBGene00000974, dhs-11, DeHydrogenases, Short chain, [Score=93.2, Expect=4e-22]} {Smed: dd_Smed_v6_2290_0_1, dd_Smed_v6_2290_0_1, [Score=97.8, Expect=1e-23]} {RNA1509_6455} {RNA1310_4640} {RNA815_8535.1} |
87. | MligTC455_15681 | 62 | 1.28 | Mlig455_036777 | Neo: - Age: - |
LRFN4 | 0.964 | - | - | 0.964 | - | - | - | Mlig455_036777 {REF} {Length: 5295} {Pfam: Leucine rich repeat [PF13855.8, score=38.6]; Leucine Rich repeats (2 copies) [PF12799.9, score=35.9]} {Human: ENSG00000173621, LRFN4, leucine rich repeat and fibronectin type III domain containing 4, [Score=66.2, Expect=1e-10]} {Mouse: ENSMUSG00000045045, Lrfn4, leucine rich repeat and fibronectin type III domain containing 4, [Score=62.8, Expect=9e-10]; ENSMUSG00000051228, Nyx, nyctalopin, [Score=60.5, Expect=4e-09]} {Dmel: FBgn0264089, sli, slit, [Score=50.4, Expect=6e-06]} {Smed: dd_Smed_v6_13555_0_1, dd_Smed_v6_13555_0_1, [Score=57.8, Expect=1e-08]} {RNA1509_44609} {RNA1310_12552.1} {RNA815_11539.1} |
88. | MligTC455_19583 | 95 | 1.97 | Mlig455_010583, Mlig455_010602 | Neo: - Age: - Region-enriched R2: 6.442/0.00383 |
0.964 | - | - | 0.964 | - | - | - | Mlig455_010583 {REF} {Length: 2325} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=173.5]} {Smed: dd_Smed_v6_23771_0_1, dd_Smed_v6_23771_0_1, [Score=320, Expect=4e-101]} {RNA1310_36131} {RNA815_32135} Mlig455_010602 {REF} {Length: 2432} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=182.9]} {Smed: dd_Smed_v6_15099_0_1, dd_Smed_v6_15099_0_1, [RH, Score=346, Expect=2e-110]} {RNA1310_36131} {RNA815_32135} |
|
89. | MligTC455_24422 | 159 | 3.31 | Mlig455_014156 | Neo: - Age: - |
TANC2 | 0.964 | - | - | - | - | 0.964 | - | Mlig455_014156 {REF} {Length: 4949} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=57.6]; Ankyrin repeats (many copies) [PF13637.8, score=49.0]; Mab-21 protein [PF03281.16, score=44.5]; Ankyrin repeat [PF13606.8, score=39.6]; Ankyrin repeat [PF00023.32, score=35.4]; Ankyrin repeats (many copies) [PF13857.8, score=31.6]} {Human: ENSG00000170921, TANC2, tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, [Score=72.0, Expect=6e-12]} {Mouse: ENSMUSG00000078487, Ankrd65, ankyrin repeat domain 65, [Score=72.8, Expect=6e-13]; ENSMUSG00000053580, Tanc2, tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, [Score=72.0, Expect=4e-12]} {Dmel: FBgn0041096, rols, rolling pebbles, [Score=68.2, Expect=4e-11]} {Celegans: WBGene00007252, mlt-2, [Score=63.2, Expect=8e-10]} {Smed: dd_Smed_v6_21003_0_1, dd_Smed_v6_21003_0_1, [Score=62.0, Expect=2e-09]} {RNA1509_17002} {RNA1310_2398} {RNA815_4370} |
90. | MligTC455_48552 | 184 | 3.84 | Mlig455_022765 | Neo: - Age: logFC(26M/2M)=0.271 Region-enriched R5: 1.403/0.03486 |
GTF2H4 | 0.964 | - | - | 0.964 | - | - | - | Mlig455_022765 {REF} {Length: 2441} {TRANSSPLICED} {Pfam: Transcription factor Tfb2 [PF03849.16, score=310.2]; Transcription factor Tfb2 (p52) C-terminal domain [PF18307.3, score=76.3]} {Human: ENSG00000226384, GTF2H4, general transcription factor IIH subunit 4, [RH, Score=314, Expect=1e-101]; ENSG00000236895, GTF2H4, general transcription factor IIH subunit 4, [RH, Score=314, Expect=1e-101]; ENSG00000221974, GTF2H4, general transcription factor IIH subunit 4, [RH, Score=314, Expect=1e-101]; ENSG00000233149, GTF2H4, general transcription factor IIH subunit 4, [RH, Score=314, Expect=1e-101]; ENSG00000234370, GTF2H4, general transcription factor IIH subunit 4, [RH, Score=314, Expect=1e-101]; ENSG00000213780, GTF2H4, general transcription factor IIH subunit 4, [RH, Score=314, Expect=1e-101]} {Mouse: ENSMUSG00000001524, Gtf2h4, general transcription factor II H, polypeptide 4, [RH, Score=314, Expect=7e-102]} {Dmel: FBgn0261109, mrn, marionette, [RH, Score=306, Expect=1e-98]} {Celegans: WBGene00013529, Y73F8A.24, General transcription factor IIH subunit 4, [RH, Score=186, Expect=2e-53]} {Smed: dd_Smed_v6_11510_0_1, dd_Smed_v6_11510_0_1, [RH, Score=172, Expect=3e-48]} {RNA1509_23204, RNA1509_41750} {RNA1310_18685, RNA1509_23204, RNA1509_41750} {RNA1509_23204, RNA1509_41750, RNA815_72.1} |
91. | MligTC455_50422 | 125 | 2.6 | Mlig455_014719 | Neo: - Age: - Region-enriched R2: 3.621/0.01085 |
GALNT1 | 0.964 | - | - | 0.964 | - | - | - | Mlig455_014719 {REF} {Length: 2844} {Pfam: Glycosyl transferase family 2 [PF00535.28, score=108.6]; N-terminal domain of galactosyltransferase [PF02709.16, score=19.9]} {Human: ENSG00000141429, GALNT1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=328, Expect=8e-108]; ENSG00000144278, GALNT13, polypeptide N-acetylgalactosaminyltransferase 13, [Score=320, Expect=1e-102]} {Mouse: ENSMUSG00000000420, Galnt1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=328, Expect=7e-106]; ENSMUSG00000060988, Galnt13, polypeptide N-acetylgalactosaminyltransferase 13, [Score=320, Expect=9e-103]} {Dmel: FBgn0050463, CG30463, [Score=349, Expect=3e-113]} {Celegans: WBGene00001630, gly-5, Polypeptide N-acetylgalactosaminyltransferase 5, [Score=359, Expect=2e-117]} {Smed: dd_Smed_v6_4615_0_1, dd_Smed_v6_4615_0_1, [Score=379, Expect=3e-125]} {RNA1509_29632} {RNA1310_10752} {RNA815_14192.1} |
92. | MligTC455_04625 | 54 | 1.12 | Mlig455_031551, Mlig455_031554 | Neo: - Age: - |
FHAD1 | 0.963 | - | - | - | - | 0.963 | - | Mlig455_031551 {REF} {Length: 1252} {Pfam: FHA domain [PF00498.28, score=38.1]; Inner membrane component of T3SS, cytoplasmic domain [PF16697.7, score=33.3]} {Smed: dd_Smed_v6_14350_0_1, dd_Smed_v6_14350_0_1, [Score=66.2, Expect=1e-11]} {RNA1509_11172} {RNA1310_2117.1} {RNA815_31030} Mlig455_031554 {REF} {Length: 5287} {Pfam: FHA domain [PF00498.28, score=36.7]; Inner membrane component of T3SS, cytoplasmic domain [PF16697.7, score=33.0]} {Human: ENSG00000142621, FHAD1, forkhead associated phosphopeptide binding domain 1, [Score=130, Expect=4e-31]} {Mouse: ENSMUSG00000051435, Fhad1, forkhead-associated (FHA) phosphopeptide binding domain 1, [Score=129, Expect=1e-29]; ENSMUSG00000116181, Fhad1, forkhead-associated (FHA) phosphopeptide binding domain 1, [Score=129, Expect=1e-29]} {Smed: dd_Smed_v6_14350_0_1, dd_Smed_v6_14350_0_1, [Score=252, Expect=3e-68]} {RNA1509_11172} {RNA1310_2117.1} {RNA815_6949} |
93. | MligTC455_15489 | 64 | 1.34 | Mlig455_007936, Mlig455_008038 | Neo: - Age: - Region-enriched R2: 5.213/0.00031 |
DIRAS2 | 0.963 | - | - | 0.963 | - | - | - | Mlig455_007936 {REF} {Length: 1262} {Pfam: Ras family [PF00071.24, score=149.3]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=66.1]; 50S ribosome-binding GTPase [PF01926.25, score=28.2]; RsgA GTPase [PF03193.18, score=27.4]; ADP-ribosylation factor family [PF00025.23, score=24.3]; Ferrous iron transport protein B [PF02421.20, score=19.3]; Elongation factor Tu GTP binding domain [PF00009.29, score=19.0]} {Human: ENSG00000165023, DIRAS2, DIRAS family GTPase 2, [RH, Score=263, Expect=1e-88]} {Mouse: ENSMUSG00000047842, Diras2, DIRAS family, GTP-binding RAS-like 2, [RH, Score=262, Expect=2e-88]} {Dmel: FBgn0037754, CG8500, [RH, Score=237, Expect=3e-78]} {Celegans: WBGene00016911, drn-1, GTP-binding protein drn-1, [RH, Score=236, Expect=4e-78]} {Smed: dd_Smed_v6_10778_0_1, dd_Smed_v6_10778_0_1, [RH, Score=245, Expect=3e-82]} {RNA1509_35041} {RNA1310_23187} {RNA815_16187} Mlig455_008038 {REF} {Length: 1497} {Pfam: Ras family [PF00071.24, score=149.3]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=66.1]; 50S ribosome-binding GTPase [PF01926.25, score=28.1]; RsgA GTPase [PF03193.18, score=27.5]; ADP-ribosylation factor family [PF00025.23, score=24.2]; Elongation factor Tu GTP binding domain [PF00009.29, score=19.1]; Ferrous iron transport protein B [PF02421.20, score=19.1]} {Human: ENSG00000165023, DIRAS2, DIRAS family GTPase 2, [RH, Score=263, Expect=1e-88]} {Mouse: ENSMUSG00000047842, Diras2, DIRAS family, GTP-binding RAS-like 2, [RH, Score=262, Expect=3e-88]} {Dmel: FBgn0037754, CG8500, [RH, Score=237, Expect=4e-78]} {Celegans: WBGene00016911, drn-1, GTP-binding protein drn-1, [RH, Score=236, Expect=5e-78]} {Smed: dd_Smed_v6_10778_0_1, dd_Smed_v6_10778_0_1, [RH, Score=246, Expect=4e-82]} {RNA1509_35041} {RNA1310_23187, RNA1509_35041} {RNA1509_35041, RNA815_16187} |
94. | MligTC455_16451 | 61 | 1.26 | Mlig455_037847 | Neo: - Age: - |
0.963 | - | - | 0.963 | - | - | - | Mlig455_037847 {REF} {Length: 931} | |
95. | MligTC455_51123 | 37 | 0.77 | Mlig455_059507 | Neo: - Age: - |
0.963 | - | - | - | - | 0.963 | - | Mlig455_059507 {REF} {Length: 970} {RNA1310_88282} | |
96. | MligTC455_10524 | 19 | 0.39 | Mlig455_039267 | Neo: - Age: - |
0.962 | - | - | - | - | 0.962 | - | Mlig455_039267 {REF} {Length: 779} {NoTransDecoderORF} {RNA1310_22208} {RNA815_54327} | |
97. | MligTC455_22841 | 20 | 0.41 | Mlig455_066350 | Neo: - Age: - |
0.962 | - | - | - | - | 0.962 | - | Mlig455_066350 {REF} {Length: 694} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_35987, RNA1509_46319} {RNA1310_35806, RNA1509_35987, RNA1509_46319} {RNA1509_35987, RNA1509_46319, RNA815_14596} | |
98. | MligTC455_41694 | 404 | 8.41 | Mlig455_026434, Mlig455_026464 | Neo: - Age: - |
SSUH2 | 0.962 | - | - | - | - | 0.962 | - | Mlig455_026434 {REF} {Length: 1709} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=210, Expect=4e-64]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=177, Expect=5e-52]} {RNA1509_35286} {RNA1310_19837, RNA1509_35286} {RNA1509_35286, RNA815_11262} Mlig455_026464 {REF} {Length: 1584} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=210, Expect=7e-64]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=178, Expect=4e-52]} {RNA1509_35286} {RNA1310_19837} {RNA815_11262} |
99. | MligTC455_14844 | 50 | 1.04 | Mlig455_003513, Mlig455_039347, Mlig455_044538, Mlig455_067570 | Neo: Germline Age: - |
PGBD4 | 0.961 | - | - | 0.961 | - | - | - | Mlig455_003513 {REF} {Length: 2351} {Pfam: Transposase IS4 [PF13843.8, score=237.9]} {Human: ENSG00000182405, PGBD4, piggyBac transposable element derived 4, [Score=136, Expect=9e-34]} {Dmel: FBgn0033750, CG13151, [Score=55.5, Expect=8e-08]} {Smed: dd_Smed_v6_13935_0_1, dd_Smed_v6_13935_0_1, [RH, Score=194, Expect=4e-58]} {RNA1509_44838} {RNA1310_12476} {RNA815_5874} Mlig455_039347 {REF} {Length: 2473} {Pfam: Transposase IS4 [PF13843.8, score=244.9]} {Human: ENSG00000182405, PGBD4, piggyBac transposable element derived 4, [Score=142, Expect=1e-35]} {Dmel: FBgn0033750, CG13151, [Score=59.3, Expect=6e-09]} {Smed: dd_Smed_v6_13935_0_1, dd_Smed_v6_13935_0_1, [RH, Score=204, Expect=2e-61]} {RNA1509_44838} {RNA1310_12476} {RNA815_5874} Mlig455_044538 {REF} {Length: 2473} {Pfam: Transposase IS4 [PF13843.8, score=244.9]} {Human: ENSG00000182405, PGBD4, piggyBac transposable element derived 4, [Score=142, Expect=1e-35]} {Dmel: FBgn0033750, CG13151, [Score=59.3, Expect=6e-09]} {Smed: dd_Smed_v6_13935_0_1, dd_Smed_v6_13935_0_1, [RH, Score=204, Expect=2e-61]} {RNA1509_44838} {RNA1310_12476, RNA1509_44838} {RNA1509_44838, RNA815_5874} Mlig455_067570 {REF} {Length: 1911} {Pfam: Transposase IS4 [PF13843.8, score=106.1]} {Human: ENSG00000182405, PGBD4, piggyBac transposable element derived 4, [Score=58.5, Expect=4e-09]} {Smed: dd_Smed_v6_13935_0_7, dd_Smed_v6_13935_0_7, [Score=115, Expect=2e-30]} {RNA1509_44838} {RNA1310_12476} {RNA815_5874} |
100. | MligTC455_15436 | 151 | 3.14 | Mlig455_001732, Mlig455_063318 | Neo: - Age: - Region-enriched R3: 3.456/0.02731 |
0.961 | - | - | 0.961 | - | - | - | Mlig455_001732 {REF} {Length: 816} {NoTransDecoderORF} {RNA1509_59156} {RNA1310_62941} {RNA815_63180} Mlig455_063318 {REF} {Length: 936} {NoTransDecoderORF} {RNA1509_59156} {RNA1310_62941} {RNA815_63180} |